Physician profile
Kenneth Brown
NPI 1588626055
$5,782.08
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,832 · 2020: $1,190 · 2021: $1,788 · 2022: $972.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,854.56 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,738.36 | 2019-2022 | |
| Gilead Sciences, INC. | $496.94 | 2019-2022 | |
| Qol Medical, LLC | $424.36 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $237.07 | 2020-2022 | |
| Daiichi Sankyo INC. | $181.91 | 2019-2020 | |
| Allergan, INC. | $169.80 | 2019 | |
| Braintree Laboratories, INC. | $129.28 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2021 | |
| Janssen Biotech, INC. | $112.01 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $72.42 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.58 | 2019 | |
| Evoke Pharma, INC. | $43.31 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $32.82 | 2019 | |
| Ucb, INC. | $19.17 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $18.97 | 2020 | |
| Celgene Corporation | $18.41 | 2021 | |
| Alfasigma USA, INC. | $14.05 | 2020 | |
| Merck Sharp & Dohme LLC | $13.11 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.19 | 2020 | |
| Olympus America INC. | $11.76 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.